Article: Picolinate and choose.(health claim petition requesting the FDA allow use of eight dietary supplement health claims associating chromium picolinate )(Brief Article)

A health claim petition requesting the FDA allow use of eight dietary supplement health claims associating chromium picolinate supplementation with reduced risk of insulin resistance, type 2 diabetes and related disease conditions has been submitted. Nutrition 21 holds patents for the therapeutic use of chromium picolinate in addressing insulin resistance and type 2 diabetes.

The FDA has accepted the health claim filing as complete and has initiated the review process. Proposed health claims include that chromium picolinate may reduce: ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!